Portfolio company
Think Bioscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ten63 Therapeutics
This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
Octant Bio
This company develops small molecule drugs for patients with protein misfolding diseases using high-throughput synthetic biology, generative chemistry and machine learning.
Tierra Biosciences
This company provides custom synthetic proteins through an AI-guided cell-free platform for pharmaceutical, industrial and agricultural researchers to accelerate bio-based product discovery.
General Biotechnologies
This company develops genetically programmed edible microbes to manufacture oral peptide therapeutics for patients with metabolic diseases and other chronic conditions.
Integrated Biosciences
The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.
Aikium
This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.
CB Therapeutics
This company uses precision fermentation and yeast engineering to manufacture rare cannabinoids, tryptamines, and food proteins for the pharmaceutical, wellness, and food industries.
